12:00 AM
Aug 05, 2013
 |  BC Week In Review  |  Company News  |  Other News

Genentech, Astellas, Mylan, Pfizer, Roche cancer news

Mylan said it entered into an agreement with Astellas' OSI Pharmaceuticals Inc. unit, Pfizer and Roche's Genentech unit to settle all patent litigation related to cancer drug Tarceva erlotinib. In 2009, OSI, Pfizer and Genentech filed a suit against Mylan in the U.S. District Court for the District of...

Read the full 245 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >